If you go back in time - 19 May 2016 - their key distributors took a placement of $7M or so at $0.21 per share - which is oddly similar to the capital refurbishment of $7M fully expensed and given as a reason for reduced sales. So they have core distributors giving a vote of confidence in the Company (CEO's words) that the Company has quite happily torched. So I wonder that money even made it into the Company, which would be an interesting question of auditors. The Pet Chairman won't tell us the truth.
- Forums
- ASX - By Stock
- XPD
- Ann: Commentary on 2016 full year results
Ann: Commentary on 2016 full year results, page-42
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XPD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online